English Journal

Le Bras J1, Ringwald P, Monsérié C, Basco LK.
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne.Rev Med Interne.1991 Jan-Feb;12(1):68-74.
Mefloquine and halofantrine are quinine-related aminoalcohols recently introduced for the oral treatment (both drugs) and oral chemoprophylaxis (mefloquine) of malaria. Soon after these new drugs were launched the volume of sales testified to the need for alternative treatments in view of the resist
PMID 2041918

[Fulminant hepatic failure induced by intermediate dose methotrexate in a case of non-Hodgkin's lymphoma].

Kaito K1, Katayama T, Yoshida M, Saito A, Kobayashi M, Ochiai S, Masuoka S, Shimada T, Nishiwaki K, Sakai O.
[Rinshō ketsueki] The Japanese journal of clinical hematology.Rinsho Ketsueki.1990 Nov;31(11):1862-7.
Methotrexate (MTX) is frequently used as an antifolics agent in many malignant neoplasms such as leukemia, lymphoma and osteosarcoma. The major side effects of MTX are liver and renal damages, bone marrow suppression and so on. But careful management and citrovorum factor rescue could decrease the i
PMID 2287073

Danis M, Gentilini M.
Archives françaises de pédiatrie.Arch Fr Pediatr.1985 Dec;42 Suppl 2:971-5.
Several drugs are used for malaria chemoprophylaxis: 4 amino-quinolines, antifolics, combinations of sulfonamides and antifolics, and new anti-malarial agents, including mefloquine. The indications and contra-indications of their use are reviewed with respect to their tolerance and pharmacokinetics.
PMID 3914247